Dr. Scott Hancock
Dr. Scott Hancock grew up in Kentucky immersed in the horse industry. He received a B.S. in Animal Science from the University of Kentucky and his DVM degree from Auburn University. Dr. Hancock began practicing in rural Amish country in Ohio and eventually moved back to the south near Atlanta, GA where he developed a full service equine surgical/referral and ambulatory practice with interests in lameness, reproduction and herd health management. Before starting with Boehringer Ingelheim in November of 2014
Dr. Hancock was recruited by the CDC to serve as attending veterinarian and project officer for a hyperimmunization project to create antibodies against biological warfare threats. Extensive travel and cooperative efforts resulted in the first FDA licensed product made from horse plasma for treating people against a deadly neurotoxin. To date, over 300 humans have received antibodies from hyperimmune horses and recovered from the deadly exposure to neurotoxins.
After 23 years of active equine veterinary practice and completion of the CDC mission, Scott decided to pursue science based medicine and is enjoying his new career at Boehringer Ingelheim working with equine veterinarians and horse owners on herd health, joint health, PPID, and equine gastric ulcer syndrome.